Work

A multicenter phase II study of istiratumab (MM-141) plus nab-paclitaxel (A) and gemcitabine (G) in metastatic pancreatic cancer (MPC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.4_suppl.tps481

Authors: Andrew H. Ko, James Murray, Kerry E Horgan, Julia Dauer, Michael Curley, Jason Baum, Chrystal Ursula Louis, Alexey Lugovskoy

Institutions: UCSF Helen Diller Family Comprehensive Cancer Center, Merrimack Pharmaceuticals (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589655149

Cites:

Cited by: 11

Related to: 10